Empaglif 10mg Tablet

✔️ Uses

• Type 2 diabetes mellitus.
• Reduction of cardiovascular risk in eligible adults with type 2 diabetes and established cardiovascular disease, where approved.

✔️ Precautions & Warnings

• Kidney function: Assess kidney function before starting treatment and monitor it periodically. Suitability depends on the patient's eGFR and the reason for treatment.
• Dehydration and hypotension: Use cautiously in older adults, people with kidney impairment, patients with low blood pressure and those taking diuretics.
• Diabetic ketoacidosis: This can occur even when blood glucose is not markedly elevated. Seek urgent medical attention if symptoms develop.
• Genital and urinary infections: Report symptoms promptly and maintain good personal hygiene.
• Low blood glucose: The risk increases when empagliflozin is combined with insulin or sulfonylureas. The prescriber may need to adjust the dose of those medicines.
• Surgery or prolonged fasting: Inform the healthcare team before surgery or procedures involving prolonged fasting. Empagliflozin is generally withheld for at least three days before scheduled surgery when recommended by current prescribing guidance.
• Alcohol: Avoid excessive alcohol consumption because it may increase the risk of dehydration and ketoacidosis.

✔️ Side Effects:

• Urinary tract infections.
• Genital fungal infections, including vaginal yeast infections and balanitis.
• Increased urination and thirst.
• Nausea.
• Dehydration, dizziness or low blood pressure.
• Changes in blood lipid levels.
• Low blood glucose, particularly when used with insulin or sulfonylureas.

✔️ Drug Interactions

• Insulin and sulfonylureas: May increase the risk of hypoglycemia.
• Diuretics: May increase urination, dehydration and low blood pressure.
• Other medicines affecting kidney function or fluid balance: May require additional monitoring.

Urine glucose tests are not reliable for monitoring blood glucose during treatment because empagliflozin increases glucose excretion through urine. Use blood glucose testing or another method recommended by your healthcare professional.

✔️ Pregnancy and Breastfeeding

Empagliflozin is generally not recommended during pregnancy, particularly during the second and third trimesters, because of potential risks to fetal kidney development. Consult a healthcare professional if pregnancy occurs or is planned.

Breastfeeding is generally not recommended during treatment because the potential effects on the infant are uncertain. A healthcare professional can recommend an appropriate alternative.

✔️ Directions for Use:

Take Empaglif 10 exactly as prescribed. It can be taken with or without food. Follow the prescribed schedule and continue recommended dietary changes, physical activity and blood glucose monitoring.

✔️ Contraindications

Empagliflozin should not be used in patients with a known serious hypersensitivity to empagliflozin or any component of the tablet. It is not indicated for treating type 1 diabetes mellitus or diabetic ketoacidosis.

Use in severe kidney impairment, end-stage kidney disease or dialysis depends on the approved product labeling and intended indication. Kidney function should be assessed before treatment.

✔️ Storage Conditions

Store below 30°C in a cool, dry place, protected from light and moisture. Keep out of the reach of children.